World's first Smartphone based offline AI expands geographical scope to deliver convenience and increase access to DR screening. BANGALORE, India, Feb. 23, 2023 /CNW/ -- Remidio has received CE mark ...

GLEN ALLEN, Va., July 7, 2022 /CNW/ -- Glaucoma, one of the world's leading causes of irreversible blindness, is expected to affect an estimated 120 million by 2040, globally. Treatment options for ...

Remidio Innovative Solutions announced the publication of a landmark independent evaluation of regulatory-approved diabetic retinopathy (DR) artificial intelligence algorithms in The Lancet Digital ...

New Delhi: In a move set to redefine non-invasive disease detection, Remidio, a global leader in AI-powered ophthalmic solutions, has invested in Occuity, a UK-based developer of handheld, optical ...

Diagnosing eye diseases requires bulky machines and specialist clinics, which are often concentrated in large cities. But for millions living in smaller towns and rural regions, access to timely eye ...

Remidio Innovative Solutions, India's leading AI-powered medical imaging company, will showcase its breakthrough eye care technology at the India AI Impact Summit 2026, demonstrating how Indian ...

Mumbai: Medical device maker Remidio Innovative Solutions has launched an automated optical biometry and autorefraction system aimed at improving accuracy and consistency in pediatric myopia ...

Bengaluru: Medtech startup Remidio has unveiled Neubo 130, an AI-powered retinal imaging device designed to diagnose neonatal retinal conditions such as Retinopathy of Prematurity (ROP). The Neubo 130 ...

CXO(s) of Remidio include Anand Sivaraman (Chief Executive Officer), Wilson D Souza (COO- Remidio India). Functional leader(s) of Remidio include Rajesh Rai (Board Director), Anand Sivaraman (Director ...

Bangalore (Karnataka) [India], February 23 (ANI/PRNewswire): Remidio has received CE mark approval for its Medios AI, to detect Referable DR. This approval closely follows the nod the AI received from ...